Literature DB >> 23765778

Detection of erythrovirus B19 in thyroidectomy specimens from Graves' disease patients: a case-control study.

Cyril Page1, Thomas Walter Hoffmann, Nassim Benzerdjeb, Gilles Duverlie, Henri Sevestre, Rachel Desailloud.   

Abstract

Environmental factors, such as viruses, are thought to contribute to the development of thyroid autoimmunity. Erythrovirus B19 (EVB19) is suspected to be involved in Hashimoto's thyroiditis, but no direct evidence is available concerning the role of EVB19 infection in Graves' disease. The objective of this study was to investigate whether the presence of EVB19 is more frequent in thyroidectomy specimens of patients undergoing thyroidectomy for Graves' disease (cases) than for multinodular thyroid (controls). Serum and thyroidectomy specimens were prospectively collected from 64 patients referred for total thyroidectomy over a 5-year period (2007-2011) and were investigated retrospectively and blindly for circulating EVB19 DNA by q-PCR (Qiagen), and for EVB19 thyrocyte infection by immunochemistry (VP2-Antibody, Dako). EVB19 serology was also determined. General clinical and laboratory data were collected. Twenty patients were referred for Graves' disease and 44 patients were referred for non-autoimmune multinodular thyroid. Patients with thyroid cancer were excluded. Ten percent of Graves' disease patients and 27.7% of control patients had positive staining of thyrocytes for EVB19 antibodies (ns). EVB19-positive and EVB19-negative cases did not differ. EVB19-positive controls were older than EVB19-negative controls (mean age: 57.5 [35-74] vs. 45 [28-80] years, P=0.03) No case of acute EVB19 infection was identified. EVB19-positive serology was more frequent in controls than in Graves' disease patients (88% vs. 45%, P<0.0001). EVB19 was detected in thyrocytes, but not more frequently in Graves' disease patients than in controls. Further studies are needed to determine the role of EVB19 infection in thyroid diseases.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765778     DOI: 10.1002/jmv.23595

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  Evolutionary aspects of Parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development.

Authors:  Piyanki Das; Koustav Chatterjee; Nabanita Roy Chattopadhyay; Tathagata Choudhuri
Journal:  Virusdisease       Date:  2019-03-26

2.  Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report.

Authors:  Laura A Adamson-Small; Larry J Fowler; Jacqueline A Hobbs
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 3.  Environmental Issues in Thyroid Diseases.

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-20       Impact factor: 5.555

4.  Orphan viruses, orphan diseases: still the raw material for virus discovery.

Authors:  Philip P Mortimer
Journal:  Rev Med Virol       Date:  2013-08-20       Impact factor: 6.989

5.  Presence of B19V in Patients with Thyroid Gland Disorders.

Authors:  Sabine Gravelsina; Zaiga Nora-Krukle; Simons Svirskis; Egils Cunskis; Modra Murovska
Journal:  Medicina (Kaunas)       Date:  2019-12-04       Impact factor: 2.430

Review 6.  The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Roberto Vita; Salvatore Benvenga; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.